Expert Review of Pharmacoeconomics and Outcomes Research

Why study pharmacoeconomics?
pp. 1-3(3)
Author: Mauskopf, Josephine A

News in Brief
pp. 4-6(3)

Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries
pp. 7-12(6)
Authors: Harris, Anthony; Buxton, Martin; O'Brien, Bernie; Drummond, Frans Rutten and Michael

Secondary prevention fallacy: pitfalls in comparing with primary
pp. 13-18(6)
Authors: Caro, J Jaime; Huybrechts, Krista F; Klittich, Wendy S

Pharmacoeconomics of Helicobacter pylori: eradication versus maintenance therapy in controlling peptic ulcer disease
pp. 19-24(6)
Authors: Klok, Rogier M; Brouwers, Jacobus RBJ; Postma, Maarten J

Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses
pp. 25-36(12)
Authors: Glick, Henry A; Briggs, Andrew H; Polsky, Daniel

Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin
pp. 37-46(10)
Authors: Craig, Bruce A; Black, Michael A

Economic evaluations of adult pneumococcal vaccination strategies
pp. 47-58(12)
Authors: Beutels, Philippe; Postma, Maarten J

Economics of fall prevention programs: evidence and research priorities
pp. 59-67(9)
Authors: Smith, Richard D; Fordham, Richard J

Cost of depression: current assessment and future directions
pp. 69-76(8)
Authors: Greenberg, Paul E; Birnbaum, Stephanie A Leongand Howard G

Pharmacoeconomic evaluation of intensified antiretroviral treatment strategies in HIV/AIDS
pp. 77-84(8)
Authors: Bos, Jasper M; Berg, Lolkje TW de Jong-van den; Postma, Maarten J

Severity of illness versus expected benefit in societal evaluation of healthcare interventions
pp. 85-92(8)
Author: Nord, Erik

Quality of life issues in gynecological cancer
pp. 93-98(6)
Authors: Greimel, Elfriede R; Bottomley, Andrew

Health-related quality of life in Parkinson's disease: outcomes of the therapeutic interventions
pp. 99-108(10)
Authors: Martínez-Martín, Pablo